Related references
Note: Only part of the references are listed.Clinical Utility and Analytical Challenges in Measurement of Cerebrospinal Fluid Amyloid-β1-42 and τ Proteins as Alzheimer Disease Biomarkers
Ju-Hee Kang et al.
CLINICAL CHEMISTRY (2013)
Soluble amyloid precursor protein a in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus
M. Miyajima et al.
EUROPEAN JOURNAL OF NEUROLOGY (2013)
Poor Cognitive Outcome in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus
Anne M. Koivisto et al.
NEUROSURGERY (2013)
Serum leucine-rich alpha-2 glycoprotein is a disease activity biomarker in ulcerative colitis
Satoshi Serada et al.
INFLAMMATORY BOWEL DISEASES (2012)
Cortactin-Binding Protein 2 Modulates the Mobility of Cortactin and Regulates Dendritic Spine Formation and Maintenance
Yi-Kai Chen et al.
JOURNAL OF NEUROSCIENCE (2012)
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Mark S. Moehle et al.
JOURNAL OF NEUROSCIENCE (2012)
Brain Localization of Leucine-Rich α2-Glycoprotein and Its Role
Madoka Nakajima et al.
HYDROCEPHALUS (2012)
Leucine-rich α-2-glycoprotein is a marker for idiopathic normal pressure hydrocephalus
Madoka Nakajima et al.
ACTA NEUROCHIRURGICA (2011)
Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Mansoureh Hakimi et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease
Zhihua Liu et al.
NATURE IMMUNOLOGY (2011)
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation
Eugenie Mutez et al.
NEUROBIOLOGY OF AGING (2011)
Regulation of LRRK2 Expression Points to a Functional Role in Human Monocyte Maturation
Jonathan Thevenet et al.
PLOS ONE (2011)
iTRAQ-based proteomic identification of leucine-rich α-2 glycoprotein as a novel inflammatory biomarker in autoimmune diseases
Satoshi Serada et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Agnes Gardet et al.
JOURNAL OF IMMUNOLOGY (2010)
LRRTMs and Neuroligins Bind Neurexins with a Differential Code to Cooperate in Glutamate Synapse Development
Tabrez J. Siddiqui et al.
JOURNAL OF NEUROSCIENCE (2010)
Up-regulation of the expression of leucine-rich α2-glycoprotein in hepatocytes by the mediators of acute-phase response
Ryoichi Shirai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
An Unbiased Expression Screen for Synaptogenic Proteins Identifies the LRRTM Protein Family as Synaptic Organizers
Michael W. Linhoff et al.
NEURON (2009)
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
Jeffrey C. Barrett et al.
NATURE GENETICS (2008)
Protective effects of NSAIDs on the development of Alzheimer disease
Steven C. Vlad et al.
NEUROLOGY (2008)
Gene expression changes in the course of normal brain aging are sexually dimorphic
Nicole C. Berchtold et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Comparative sequence analysis of leucine-rich repeats (LRRs) within vertebrate toll-like receptors
Norio Matsushima et al.
BMC GENOMICS (2007)
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
Patrick L. McGeer et al.
NEUROBIOLOGY OF AGING (2007)
Inflammatory processes in Alzheimer's disease
Michael T. Heneka et al.
JOURNAL OF NEUROIMMUNOLOGY (2007)
Analysis of potential diagnostic biomarkers in cerebrospinal fluid of idiopathic normal pressure hydrocephalus by proteomics
X. Li et al.
ACTA NEUROCHIRURGICA (2006)
LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs
S Lesage et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease
HL Chen et al.
ANNALS OF NEUROLOGY (2005)
Acute treatment with the PPARγ agonist pioglitazone and ibuprofen reduces glial inflammation and Aβ1-42 levels in APPV717I transgenic mice
MT Heneka et al.
BRAIN (2005)
An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family
M Funayama et al.
ANNALS OF NEUROLOGY (2005)
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism:: Evidence of a common founder across European populations
J Kachergus et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
The leucine-rich repeat as a protein recognition motif
B Kobe et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2001)
hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo
L Zhuo et al.
GENESIS (2001)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Share Paper
